Scientific Library
- Acute Coronary Syndrom
- ASCVD Prevention
- Bifurcation Stenting
- Cardio-Oncology
- Congestive Heart Failure
- DAPT Duration
- Drug Coated Balloon
- Fractional Flow Reserve
- IVUS Guidance
- Optical Coherence Tomography
- Pulmonary Hypertension
- Rotational Atherectomy
- Shear Stress
- Stenting Left Main
- Transcatheter Aortic Valve Replacement
- Percutaneous LAA Occlusion
- Mitral/Tricuspid Valvular Disease
- Other Relevant Articles
-
Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trialP Vranckx, M Valgimigli, A Goette et al. -
Anticoagulation in Concomitant Chronic Kidney Disease and Atrial Fibrillation: JACC Review Topic of the WeekS Kumar, E Lim, A Covic et al.
-
Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trialOldgren J, Steg PG, Hohnloser SH et al.
-
Procedural and Short-Term Results With the New Watchman FLX Left Atrial Appendage Occlusion DeviceIgnacio Cruz-Gonzalez 1 , Kasper Korsholm 2 , Blanca Trejo-Velasco
-
Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trialHolmes DR, Reddy VY, PROTECT AF Investigators.
-
An artificial intelligence-enabled ECG algorithm for the identification of patients with atrial fibrillation during sinus rhythm: a retrospective analysis of outcome predictionAttia ZI, Noseworthy PA, Lopez-Jimenez F et al.
-
Percutaneous left atrial appendage occlusion: the Munich consensus document on definitions, endpoints, and data collection requirements for clinical studiesTzikas A, Holmes DR Jr, Lewalter T et al.
-
2015 ACC/HRS/SCAI Left Atrial Appendage Occlusion Device Societal OverviewMasoudi FA, Calkins H, Kavinsky CJ.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
